Initial low ‐dose oral levothyroxine in a child with Down syndrome, myxedema, and cardiogenic shock

Myxedema is extremely rare in children, and guidelines are lacking. We treated a 12 ‐year‐old girl with myxedema and cardiogenic shock with initial low dose (0.3‐2.5 μg/kg body weight/day) of oral levothyroxine and intensive care. Oral administration may safely revert children's myxedema in a dosage resembling that for hypothyroidism. AbstractMyxedema is extremely rare in children, and guidelines are lacking. We treated a 12 ‐year‐old girl with myxedema and cardiogenic shock with initial low dose (0.3‐2.5 μg/kg body weight/day) of oral levothyroxine and intensive care. Oral administration may safely revert children's myxedema in a dosage resembling that for hypothyroidism.

Source: Clinical Case Reports - May 19, 2019 Category: General Medicine Authors: Annika Janson, Cathrin H ällström, Magnus Iversen, Mikael Finder, Amira Elimam, Ricard Nergårdh Tags: CASE REPORT Source Type: research